Subject category:
Strategy and General Management
Published by:
International Institute for Management Development (IMD)
Length: 6 pages
Data source: Published sources
Share a link:
https://casecent.re/p/128460
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
This is part of a case series. The second part of this case series describes the protests about the cost of Sovaldi which continued throughout the summer of 2014, not only in emerging markets but also in developed countries. In PR terms, Gilead was being painted less as a marvelous creator of a miracle drug and more as an arbiter of who might live or die from hepatitis C, based entirely on whether they could afford it or not. In September 2014, Gilead surprised everyone.
Location:
Industry:
Size:
Revenue of USD24,890 million 7,000 employees
Subject category:
Strategy and General Management
Published by:
International Institute for Management Development (IMD)
Length: 10 pages
Data source: Published sources
About
Abstract
This is part of a case series. The second part of this case series describes the protests about the cost of Sovaldi which continued throughout the summer of 2014, not only in emerging markets but also in developed countries. In PR terms, Gilead was being painted less as a marvelous creator of a miracle drug and more as an arbiter of who might live or die from hepatitis C, based entirely on whether they could afford it or not. In September 2014, Gilead surprised everyone.
Settings
Location:
Industry:
Size:
Revenue of USD24,890 million 7,000 employees
Related
Subject category:
Strategy and General Management
Published by:
International Institute for Management Development (IMD)
Length: 10 pages
Data source: Published sources